The independent source for health policy research, polling, and news.
7,421 - 7,440 of 15,445 Results
Most acquisitions by hospitals of physician practices are too small to trigger antitrust attention, study says. But a buying spree of “onesies and twosies” doctor practices has driven competition down and prices up.
New research offers evidence that coverage expansion policies for adults have a positive spillover effect for kids.
No longer able to get exemptions for personal beliefs in California, parents opposed to inoculations seem to be obtaining medical exemptions for their children, according to a new study.
Several state-based exchanges and the District of Columbia will allow people more than the 45 days set by the Trump administration.
Happy doesn’t always mean healthy. These older adults are still finding joy in spite of their physical challenges.
Fed up with high hospital costs and limited competition, Santa Barbara County sends willing employees out of town for better bargains. Local governments are slowly joining private employers in aggressively seeking out the best care for the lowest price.
The federal government plans to spend millions of dollars less this year on advertising and outreach efforts to support the health law’s open enrollment period, which starts Nov. 1.
Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.
After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the potential health impact of Hurricane Harvey on the Texas Gulf Coast, and what impact the relief effort in Washington could have on an already jampacked September agenda. Also this week: an interview with Elisabeth Rosenthal about why medical care costs so much.
Study suggests that many small tumors are sleepy, not deadly.
New research bolsters evidence that older adults with a sense of purpose are less likely to see their health decline with age. The question is: How does one cultivate more meaning and motivation in life?
The USA's first approved gene therapy — to be used to fight leukemia that resists standard therapies — will cost $475,000 for a one-time treatment.
As lawmakers look for ways to stabilize the health law marketplaces, a number of ideas — such as expanding who can “buy in” to Medicare and Medicaid or pushing young adults off their parents’ plans into the marketplaces — might come into play.
In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
Painkillers were never designed to be used over the long term, says the head of the Mayo Clinic’s pain rehabilitation center. Instead, patients should try other approaches, including relaxation therapies. But getting insurers to cover them might take coaxing.
Prominent businessmen and an American university supported offshore testing of an experimental vaccine.
An emergency department at New York-Presbyterian Hospital trains staff to recognize signs of elder abuse and help victims.
State lawmakers in California have an answer: legislation that would require your new insurer to keep paying for your current doctors even if they’re not in the network.
A breast cancer survivor and author has helped numerous patients explore the feelings awakened by their disease — and feel better.
© 2026 KFF